Hologic, Inc. (HOLX) - Financial and Strategic SWOT Analysis Review

Date: May 24, 2016
Pages: 62
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: HFC0F420C66EN
Leaflet:

Download PDF Leaflet

Hologic, Inc. (HOLX) - Financial and Strategic SWOT Analysis Review
Hologic, Inc. (HOLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Hologic, Inc. (Hologic) is a medical device company. It develops, manufactures and supplies diagnostic products, medical imaging systems and surgical products. The company offers diagnostic products to aid in the diagnosis of human diseases and screen donated human blood; a broad portfolio of breast imaging and related products and accessories; gynecology surgical products including endometrial ablation system and hysteroscopic tissue removal system; and skeletal health products including dual-energy X-ray bone densitometry systems and mini C-arm imaging products. The company offers these solutions to surgeons, hospitals, clinical laboratories and healthcare providers. Hologic sells and services its products through a net work of direct sales and service forces and through independent distributors and sales representatives. The company operates in Americas, Europe and Asia-Pacific. Hologic is headquartered in Marlborough, Massachusetts, the US.

Hologic, Inc. Key Recent Developments

Apr 27, 2016: Hologic Announces Financial Results for Second Quarter of Fiscal 2016
Mar 02, 2016: Chris Coughlin Elected to Hologic Board of Directors
Jan 27, 2016: Hologic Announces Financial Results for First Quarter of Fiscal 2016
Jan 19, 2016: Hologic’s Tepnel Pharma Services Achieves ISO 17025 Accreditation for Extraction and Genotyping Services
Dec 21, 2015: Hologic Applauds Passage of Federal Measures that Preserve Access to Mammography for Breast Cancer Screening and Increase Incentives for Biomedical Research and Development

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Hologic, Inc. - Key Facts
Hologic, Inc. - Key Employees
Hologic, Inc. - Key Employee Biographies
Hologic, Inc. - Major Products and Services
Hologic, Inc. - Medical Equipment Pipeline Products Data
Hologic, Inc. Pipeline Products by Equipment Type
Hologic, Inc. Pipeline Products by Development Stage
Hologic, Inc. - History
Hologic, Inc. - Company Statement
Hologic, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Hologic, Inc. - Business Description
Business Description - Breast Health Segment
Breast Health Segment - Overview
Breast Health Segment - Financials
Breast Health Segment - Capital Expenditure
Business Description - Diagnostics Segment
Diagnostics Segment - Overview
Diagnostics Segment - Financials
Diagnostics Segment - Capital Expenditure
Business Description - GYN Surgical Segment
GYN Surgical Segment - Overview
GYN Surgical Segment - Financials
GYN Surgical Segment - Capital Expenditure
Business Description - Skeletal Health Segment
Skeletal Health Segment - Overview
Skeletal Health Segment - Financials
Skeletal Health Segment - Capital Expenditure
Hologic, Inc. - Corporate Strategy
Hologic, Inc. - SWOT Analysis
SWOT Analysis - Overview
Hologic, Inc. - Strengths
Strength - Research and Development
Strength - Strong Sales and Distribution Network
Strength - Improved Business Performance
Hologic, Inc. - Weaknesses
Weakness - Patent Infringement Concerns
Weakness - Product Safety Concerns
Hologic, Inc. - Opportunities
Opportunity - Product Approvals
Opportunity - Growing IVD Market
Opportunity - Mammography Equipment Market
Hologic, Inc. - Threats
Threat - Stiff Competition
Threat - Dependence on Limited Customers
Threat - Dependence on Third Party Manufacturers
Threat - Regulations from RoHS and WEEE
Hologic, Inc. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Hologic, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Hologic, Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016
Hologic, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Hologic, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Hologic, Inc., Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 27, 2016: Hologic Announces Financial Results for Second Quarter of Fiscal 2016
Mar 02, 2016: Chris Coughlin Elected to Hologic Board of Directors
Jan 27, 2016: Hologic Announces Financial Results for First Quarter of Fiscal 2016
Jan 19, 2016: Hologic’s Tepnel Pharma Services Achieves ISO 17025 Accreditation for Extraction and Genotyping Services
Jan 06, 2016: Metamark Genetics to Serve as Exclusive Sales Agent for Hologic’s Proprietary Prostate Cancer Test
Dec 21, 2015: Hologic Applauds Passage of Federal Measures that Preserve Access to Mammography for Breast Cancer Screening and Increase Incentives for Biomedical Research and Development
Nov 04, 2015: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2015
Oct 20, 2015: Hologic Receives European Regulatory Approval for New Molecular Test to Confirm Hepatitis C Infection and Quantify Viral Load
Jul 29, 2015: Hologic Announces Financial Results for Third Quarter of Fiscal 2015
Jun 17, 2015: Hologic Announces Changes to Board of Directors

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Hologic, Inc., Key Facts
Hologic, Inc., Key Employees
Hologic, Inc., Key Employee Biographies
Hologic, Inc., Major Products and Services
Hologic, Inc. Number of Pipeline Products by Equipment Type
Hologic, Inc. Pipeline Products by Equipment Type
Hologic, Inc. Number of Pipeline Products by Development Stage
Hologic, Inc. Pipeline Products by Development Stage
Hologic, Inc., History
Hologic, Inc., Other Locations
Hologic, Inc., Subsidiaries
Hologic, Inc., Key Competitors
Hologic, Inc., Ratios based on current share price
Hologic, Inc., Annual Ratios
Hologic, Inc., Interim Ratios
Hologic, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Hologic, Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016
Hologic, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Hologic, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Hologic, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Hologic, Inc. Pipeline Products by Equipment Type
Hologic, Inc. Pipeline Products by Development Stage
Hologic, Inc., Performance Chart (2011 - 2015)
Hologic, Inc., Ratio Charts
Hologic, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Hologic, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Hologic, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Hologic, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

COMPANIES MENTIONED

Johnson & Johnson
GI Dynamics, Inc.
Qiagen N.V.
Intact Medical Corporation
Siemens AG
Fujirebio US Inc.
Sanarus Technologies, LLC
CareFusion Corporation
Roche Diagnostics Corporation
Boston Scientific Corporation
Becton, Dickinson and Company
C. R. Bard, Inc.
Skip to top


Ask Your Question

Hologic, Inc. (HOLX) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: